|
1
|
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
|
Leukemia
|
2005
|
1.39
|
|
2
|
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).
|
Leukemia
|
2007
|
1.10
|
|
3
|
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma.
|
Leukemia
|
2006
|
1.04
|
|
4
|
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma.
|
Leukemia
|
2007
|
0.97
|
|
5
|
Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33).
|
Leukemia
|
2009
|
0.97
|
|
6
|
Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation.
|
J Clin Pathol
|
2011
|
0.87
|
|
7
|
Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation.
|
Sex Dev
|
2011
|
0.86
|
|
8
|
Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL.
|
Cancer Genet Cytogenet
|
2001
|
0.81
|
|
9
|
Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
|
J Invest Dermatol
|
2004
|
0.79
|
|
10
|
Cytogenetic and molecular characterization of simultaneous chronic and acute myelocytic leukemia.
|
Cancer Genet Cytogenet
|
2003
|
0.79
|
|
11
|
Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis.
|
Leukemia
|
2001
|
0.78
|
|
12
|
Centrosome abnormalities in ALK-positive anaplastic large-cell lymphoma.
|
Leukemia
|
2004
|
0.78
|